Analyst Price Targets — WST
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 2:34 pm | Dan Leonard | UBS | $340.00 | $246.60 | TheFly | West Pharmaceutical price target lowered to $340 from $355 at UBS |
| February 13, 2026 1:36 pm | — | Deutsche Bank | $315.00 | $247.49 | TheFly | West Pharmaceutical price target raised to $315 from $310 at Deutsche Bank |
| February 13, 2026 11:23 am | Luke Sergott | Barclays | $265.00 | $243.61 | TheFly | West Pharmaceutical price target lowered to $265 from $325 at Barclays |
| February 10, 2026 2:10 pm | David Windley | Jefferies | $295.00 | $249.97 | TheFly | West Pharmaceutical price target lowered to $295 from $365 at Jefferies |
| February 3, 2026 1:02 pm | Daniel Markowitz | Evercore ISI | $320.00 | $237.88 | TheFly | West Pharmaceutical price target lowered to $320 from $390 at Evercore ISI |
| December 1, 2025 9:26 pm | — | Morgan Stanley | $285.00 | $274.14 | TheFly | West Pharmaceutical initiated with an Equal Weight at Morgan Stanley |
| October 27, 2025 12:39 pm | — | Barclays | $325.00 | $293.62 | TheFly | West Pharmaceutical price target raised to $325 from $275 at Barclays |
| October 24, 2025 12:18 pm | Dan Leonard | UBS | $355.00 | $307.25 | TheFly | West Pharmaceutical price target raised to $355 from $320 at UBS |
| October 24, 2025 11:17 am | Justin Bowers | Deutsche Bank | $345.00 | $304.74 | TheFly | West Pharmaceutical price target raised to $345 from $305 at Deutsche Bank |
| October 23, 2025 3:50 pm | Daniel Markowitz | Evercore ISI | $390.00 | $309.28 | TheFly | West Pharmaceutical price target raised to $390 from $350 at Evercore ISI |
Latest News for WST
Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks?
West Pharmaceutical Services (NYSE: WST - Get Free Report) and Henry Schein (NASDAQ: HSIC - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability. Valuation and Earnings This table compares West
EXTON, Pa., Feb. 27, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: Barclays Global Healthcare Conference: Fireside chat at 9:00 AM EDT on Tuesday, March 10, 2026 KBCM Healthcare Forum: Fireside chat at 1:30 PM EDT on Wednesday, March…
Artisan Partners Limited Partnership grew its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 22.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,770,920 shares of the medical instruments supplier's stock after purchasing an additional 503,601 shares
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.